4-Cyclopentanecarbonylpyridine

Catalog No.: 
ACLSHC876
CAS No.: 
60148-11-0
Molecular Formula: 
C11H13NO
Molecular Weight: 
175.23
4-Cyclopentanecarbonylpyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg98%$124.00InquiryInquiry
1g98%$367.00InquiryInquiry
5g98%$1067.00InquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Cyclopentanecarbonylpyridine
IUPAC Namecyclopentyl(pyridin-4-yl)methanone
MDL No.MFCD12153291
Molecular FormulaC11H13NO
Molecular Weight175.23
SMILESO=C(C1=CC=NC=C1)C2CCCC2
InChI KeyHWBBYZHHLIGOLW-UHFFFAOYSA-N
SynonymMethanone, cyclopentyl-4-pyridinyl-;4-CYCLOPENTANECARBONYLPYRIDINE;cyclopentyl(pyridin-4-yl)methanone;Cyclopentyl-4-pyridinylmethanone
CAS No.60148-11-0

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P302+P352-P304+P340-P305+P351+P338-P312-P330-P362-P403+P233-P501

Synthetic Route by SureRoute

1. ACLSHC876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACWGDT861 route compound structure diagram
    ACWGDT8614524-93-0In Stock
  2. Plus
  3. ACABCJ598 route compound structure diagram
    ACABCJ59852193-54-1In Stock
  4. Then
  5. ACLSHC876 route product structure diagram
    ACLSHC87660148-11-0
Inquiry

2. ACLSHC876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOZRV135 route compound structure diagram
    ACOZRV13519524-06-2In Stock
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLSHC876 route product structure diagram
    ACLSHC87660148-11-0
Inquiry

3. ACLSHC876 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACLSHC876 route product structure diagram
    ACLSHC87660148-11-0
Inquiry

Comments (0)